ForSight Robotics Secures $125M in Funding Round Led by Eclipse Ventures

ForSight Robotics Ltd. has raised $125 million in funding led by Eclipse Ventures, LLC, with participation from an undisclosed strategic investor and individual investor Fred Moll. This round brings the company's total funding to $195 million. The funding will support the company's growth and development in the robotics industry.

ForSight Robotics Ltd., a pioneering surgical robotics company, has secured $125 million in Series B funding led by Eclipse Ventures, LLC. The funding round, completed on June 24, 2025, brings the company's total funding to $195 million. The investment will support the company's growth and development in the robotics industry, particularly in the field of ophthalmic surgery.

The funding round was significantly participated in by an undisclosed strategic investor and individual investor Fred Moll. The company has already attracted notable investors, including Adani Enterprises Limited, Reiya Ventures, and other existing investors. The Series B funding will accelerate the next growth phase for the ORYOM™ Platform, the world’s first robotic surgery platform for cataract and other eye diseases.

The ORYOM™ Platform, designed to enhance surgical precision and increase patient access to high-quality treatment, will undergo first-in-human clinical trials this year. The platform is engineered for highly precise and consistent ophthalmic procedures, utilizing AI-based algorithms, advanced computer vision, and micromechanics. The goal is to deliver unprecedented dexterity and maneuverability, providing surgeons with an improved ergonomic experience.

The global vision crisis, where over one billion people suffer from preventable vision impairment and avoidable blindness, underscores the urgency for innovative solutions. The ORYOM™ Platform aims to address this crisis by providing access to high-quality treatment for millions of patients worldwide.

ForSight Robotics, founded by Prof. Moshe Shoham, Dr. Daniel Glozman, and Dr. Joseph Nathan, has expanded its executive team and achieved ISO 13485:2016 certification, demonstrating its commitment to safety and quality. The company has doubled in size, surpassing 110 employees, and has successfully completed hundreds of procedures on animal eye models.

The Series B funding comes on the heels of a period of rapid growth and key achievements. ForSight Robotics is set to begin robotic cataract surgery clinical trials in the coming year. The company has also convened a strategic advisory board of preeminent leaders in surgical robotics, including Dr. Fred Moll, the founder of Intuitive Surgical and the da Vinci surgical system, and Mr. Rony Abovitz, the founder of MAKO Surgical Corp.

The funding will enable ForSight Robotics to scale its operations and continue its mission to democratize quality surgical eye care. With a strong foundation of technology, expertise, and funding, the company is well-positioned to make a significant impact on global eye care.

References:
[1] https://www.marketscreener.com/quote/stock/ADANI-ENTERPRISES-LIMITED-6498499/news/ForSight-Robotics-Ltd-announced-that-it-has-received-125-million-in-funding-from-Eclipse-Ventures-50323317/
[2] https://www.biospace.com/press-releases/forsight-robotics-secures-125m-in-series-b-funding-addressing-global-surgeon-shortage-and-exploding-demand-for-ophthalmic-surgery